January Salas-McKee, PhD

Dr. January Salas-McKee received her B.S. Pharmacy in San Carlos University (1999) and Ph.D. from the University of Navarra under the program of Hepatology and Gene Therapy (2008). Her doctoral thesis was studying the role of anion transporter (AE2) in regulation of intracellular pH in lymphocytes activation under the supervision of Dr. Juan F. Medina and Dr. Jesus Prieto. In 2010, she worked with Dr. Suzanne Topalian at Johns Hopkins studying MHC class II-associated phosphopeptides as target antigens for melanoma vaccines and on PD1-PDL1 checkpoint blockade focusing on biomarkers and functional immune response in clinical trials conducted by Bristol-Myer Squibb (now Nivolumab). She CVPF in 2015 where her primary role was to validate and scale-up promising pre-clinical studies/protocols to bring to Phase I trial.